hrp0082p1-d2-73 | Diabetes (1) | ESPE2014
Morikawa Shuntaro , Nakamura Akie , Ishizu Katsura , Kumaki Satoru , Tajima Toshihiro
hrp0092p1-406 | Pituitary, Neuroendocrinology and Puberty (2) | ESPE2019
Yamaguchi Tomoe , Terashita Shintaro , Kinjo Kenichi , Fujisawa Yusuke , Yoshii Keisuke , Naiki Yasuhiro , Horikawa Reiko
hrp0084p2-296 | Diabetes | ESPE2015
Horikawa Reiko , Arata Naoko , Naiki Yasuhiro
hrp0094p2-280 | Growth and syndromes (to include Turner syndrome) | ESPE2021
AL Jorge Alexander , Pietropoli Alberto , Kelepouris Nicky , Horikawa Reiko ,
hrp0097p1-271 | Fat, Metabolism and Obesity | ESPE2023
Doi Hibiki , Yoshii Keisuke , Naiki Yasuhiro , Horikawa Reiko
hrp0097p2-2 | Multisystem Endocrine Disorders | ESPE2023
Ujita Nagisa , Igarashi Mizuho , Yoshii Keisuke , Naiki Yasuhiro , Horikawa Reiko
hrp0095p2-59 | Diabetes and Insulin | ESPE2022
Aralbayeva Dariga , Bolatbek Kassiyet , Berikkan Aigerim , Ten Svetlana , Bhangoo Amrit , Nurbekova Akmaral
hrp0095p1-108 | Growth and Syndromes | ESPE2022
Efficacy, Observer-Reported Outcomes, and Safety of Once-Weekly Somapacitan in Children with Growth Hormone Deficiency (GHD): 4-Year Results from the REAL 3 Trial
Sävendahl Lars , Battelino Tadej , Højby Rasmussen Michael , Brod Meryl , Wai Lee Kai , Saenger Paul , Horikawa Reiko
hrp0095p1-393 | Thyroid | ESPE2022
Igarashi Mizuho , Kashima Takemoto , Hibiki Doi , Yoshii Keisuke , Naiki Yasuhiro , Horikawa Reiko
hrp0092lb-1 | Late Breaking Posters | ESPE2019
Horikawa Reiko , Ogata Tsutomu , Matsubara Yoichi , Yokoya Susumu , Ogawa Yoshihisa , Nishijima Keiji , Endo Takaaki , Ozono Keiichi